| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5884798 | Journal of Clinical Anesthesia | 2016 | 5 Pages |
Abstract
A continuous high-dose infusion of octreotide acetate intraoperatively minimizes the incidence of carcinoid crisis. We believe that the low cost and excellent safety profile of octreotide warrant the use of this therapy during extensive surgical procedures for midgut and foregut NETs.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Eugene A. MD, Anne E. BS, BSN, Melissa A. MPH, Yi-Zarn MD, John P. MD, Gregg MS, James M. MD, Alan D. MD, PhD,